Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Devkalpi Industries is an Indian pharmaceutical company specializing in the manufacture and export of Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediates. Based in Ahmedabad, Gujarat, the company focuses heavily on the antidiabetic therapeutic segment, producing high-demand molecules such as Metformin, Sitagliptin, and Vildagliptin. Devkalpi Industries serves a global clientele, providing cost-effective and high-quality chemical components for finished dosage formulations in both regulated and semi-regulated markets. Their manufacturing operations are designed to meet international quality standards, positioning them as a reliable supplier in the global pharmaceutical supply chain. The company's portfolio supports the production of essential medications for chronic disease management, particularly in metabolic and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Devkalpi Industries.